Cell-Based Models of ‘Cytokine Release Syndrome’ Endorse CD40L and Granulocyte–Macrophage Colony-Stimulating Factor Knockout in Chimeric Antigen Receptor T Cells as Mitigation Strategy

While chimeric antigen receptor (CAR) T cell therapy has shown promising outcomes among patients with hematologic malignancies, it has also been associated with undesirable side-effects such as cytokine release syndrome (CRS). CRS is triggered by CAR T-cell-based activation of monocytes, which are s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dibas, Ala, Rhiel, Manuel, Patel, Vidisha Bhavesh, Andrieux, Geoffroy, Boerries, Melanie, Cornu, Tatjana I., Alzubi, Jamal, Cathomen, Toni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649043/
https://www.ncbi.nlm.nih.gov/pubmed/37947658
http://dx.doi.org/10.3390/cells12212581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649043/
https://www.ncbi.nlm.nih.gov/pubmed/37947658
http://dx.doi.org/10.3390/cells12212581

Ejemplares similares